combination product: Vosevi. It is use for treatment of adults with chronic hepatitis C virus (HCV) genotypes 1–6 without cirrhosis or with mild cirrhosis. It’s department is under Biologics Regulation, CBER. And requires Premarket Approval Application (PMA). A CBER ->…   Read more»